Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years
- Conditions
- Adverse Drug ReactionsAdverse Drug Events
- Interventions
- Registration Number
- NCT01764204
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Brief Summary
To highlight the incidence of adverse reactions of Qingkailing Injection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30840
- all the patients treated by Qingkailing Injection in the certain centers(hospitals) in the next 2 years.
- in accordance with ethics requirements.
- none.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Qingkailing Injection Qingkailing Injection -
- Primary Outcome Measures
Name Time Method incidence of severe adverse drug reactions 2 years
- Secondary Outcome Measures
Name Time Method incidence of adverse drug reactions 2 years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (48)
National Defense University Hospital of People's Liberation Army
🇨🇳Beijing, Beijing, China
Ren'ai Hospital
🇨🇳Shenzhen, Guangdong, China
Chinese Medicine Hospital of Deqing County
🇨🇳Zhaoqing, Guangdong, China
Chinese Medicine Hospital of Gaoyang County
🇨🇳Baoding, Hebei, China
Gaoyang County Hospital
🇨🇳Baoding, Hebei, China
The Third People's Hospital of Xiong County
🇨🇳Baoding, Hebei, China
Chinese Medicine Hospital of Xiong County
🇨🇳Baoding, Hebei, China
Chinese Medicine Hospital of Tang County
🇨🇳Baoding, Hebei, China
People's Hospital of Tang County
🇨🇳Baoding, Hebei, China
Chinese Medicine Hospital of Handan City
🇨🇳Handan, Hebei, China
Scroll for more (38 remaining)National Defense University Hospital of People's Liberation Army🇨🇳Beijing, Beijing, China